Equity Financing - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands			3 Months Ended		9 Months Ended		12 Months Ended
	Nov. 09, 2023	Aug. 31, 2022	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022
Subsidiary Sale Of Stock [Line Items]
Number of stock, authorized for issuance			10,000,000		10,000,000		10,000,000
Number of stock, par value per share			$ 0.0001		$ 0.0001		$ 0.0001
Number of stock, shares issued			0		0		0
Number of stock, shares outstanding			0		0		0
Common stock, shares authorized			300,000,000		300,000,000		300,000,000
Common stock, par value per share			$ 0.0001		$ 0.0001		$ 0.0001
Common stock, shares issued			16,850,350		16,850,350		16,784,969
Common stock, voting rights					one vote per share		one vote per share
Common stock, shares outstanding			16,850,350		16,850,350		16,784,969
Gain (loss) on warrant liability					$ 2,407	$ 2,283
Inducement Offer
Subsidiary Sale Of Stock [Line Items]
Gain (loss) on warrant liability			$ 100	$ 0	1,000	$ 0
Estimated Fair Value of Common Warrants Outstanding			$ 2,100		$ 2,100		$ 3,100
Common Stock
Subsidiary Sale Of Stock [Line Items]
Common stock, shares outstanding			16,850,350	14,614,890	16,850,350	14,614,890	16,784,969	16,847,622	16,786,647	14,595,477	14,359,214	14,215,302
Existing Warrants | Holders | Inducement Offer
Subsidiary Sale Of Stock [Line Items]
Warrants issued to purchase ordinary shares	2,143,000
Reduced exercise price of warrant	$ 2.045
Expected aggregate gross proceeds from exercise of warrants	$ 4,400
New Warrants | Holders | Inducement Offer
Subsidiary Sale Of Stock [Line Items]
Exercise price for warrant	$ 1.92
Warrants issued to purchase ordinary shares	2,143,000
New Warrants | Holders | Inducement Offer | Maximum
Subsidiary Sale Of Stock [Line Items]
Warrants exercisable term	5 years
Placement Agent Warrants | H.C. Wainwright & Co.
Subsidiary Sale Of Stock [Line Items]
Exercise price for warrant	$ 2.5563
Warrants issued to purchase ordinary shares	128,580
Follow-On Offering
Subsidiary Sale Of Stock [Line Items]
Gross proceeds		$ 45,000
Gain (loss) on warrant liability			$ 100	$ 300	$ 1,400	$ 2,300
Proceeds from sale of common stock		$ 41,700
Number of warrants exercised			2,143,000		2,143,000
Estimated Fair Value of Common Warrants Outstanding			$ 1,400		$ 1,400		$ 2,800
Follow-On Offering | Maximum
Subsidiary Sale Of Stock [Line Items]
Warrants exercisable term		5 years
Warrant exercise percentage of ordinary shares outstanding beneficially owned		4.99%
Follow-On Offering | Common Stock
Subsidiary Sale Of Stock [Line Items]
Issuance of common stock (in shares)		6,428,571
Share purchase price		$ 7
Follow-On Offering | Existing Warrants
Subsidiary Sale Of Stock [Line Items]
Exercise price for warrant		$ 8.5
Warrants issued to purchase ordinary shares		6,428,572